Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children

Athanasios G Kaditis1, Emmanouel I Alexopoulos, Eleni Damani

  • 1Department of Pediatrics, University of Thessaly School of Medicine and Larissa University Hospital, Larissa, Greece.

Pediatric Pulmonology
|September 30, 2005
PubMed

Insights

In nonobese children who snore, sleep-disordered breathing severity doesn't predict insulin levels. However, relative body mass index is linked to fasting insulin and HOMA index values.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Metabolic Health

Background:

  • Sleep-disordered breathing (SDB) correlates with insulin resistance in adults and obese children.
  • The relationship between SDB and metabolic markers in nonobese children is less understood.

Purpose of the Study:

  • To investigate if SDB severity and relative body mass index predict fasting insulin and Homeostasis Model Assessment (HOMA) index in nonobese children with habitual snoring.

Main Methods:

  • 110 nonobese children with habitual snoring underwent polysomnography.
  • Fasting insulin, glucose, and relative body mass index were measured.
  • HOMA index was calculated.

Main Results:

  • No significant difference in insulin or HOMA index values was found between children with and without SDB (AHI >= 5 vs. AHI < 5).
  • No significant correlations were identified between polysomnography indices and insulin or HOMA index values.
  • Relative body mass index, but not SDB severity (AHI or sleep time with saturation <95%), significantly predicted insulin and HOMA index values.

Conclusions:

  • Contrary to findings in adults and obese children, SDB severity does not predict fasting insulin or HOMA index in nonobese children who habitually snore.
  • Relative body mass index is a significant predictor of insulin resistance markers in this population.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...